Please ensure Javascript is enabled for purposes of website accessibility

Aphria Is Becoming the Stock Market's Biggest Merger Arbitrage Play

By Dan Caplinger - Feb 10, 2021 at 1:00PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Stocks were volatile on Wednesday, with the marijuana industry once again taking center stage.

Wednesday brought more volatility to the stock market. After posting early gains to push further into record territory, most major market benchmarks pulled back by midmorning. At 11:45 a.m. EST, the Dow Jones Industrial Average (^DJI 2.68%) was down 7 points to 31,369. The S&P 500 (^GSPC 3.06%) had fallen 6 points to 3,905, and the Nasdaq Composite (^IXIC 3.34%) had moved lower by 54 points to 13,954.

Investors remained squarely focused on marijuana stocks, as ongoing activity in the cannabis space continues to draw interest from those looking to put their money to work in areas with solid growth prospects. However, one thing that's getting a rising amount of attention is the growing disconnect between shares of Tilray (TLRY) and shares of Aphria (APHA), with some seeing the divergence as a potential merger arbitrage opportunity.

Dried cannabis in a jar with a scoop and lid nearby.

Image source: Getty Images.

How the Tilray-Aphria merger should work

Both Aphria and Tilray shares soared in mid-December, when the two companies first announced their merger. Investors were pleased to see consolidation in the cannabis industry, and the combination of Tilray and Aphria promised to create the largest marijuana company in the world in terms of revenue. That would potentially put the combined company in a much better competitive position against industry giants like Canopy Growth (CGC 4.72%).

Under the terms of the deal, Aphria investors could expect to receive 0.8381 shares of Tilray stock. Tilray shareholders will simply keep their shares. Because Aphria was the larger company by market capitalization, it was Tilray shareholders who ended up getting a premium price in consummating the deal.

As you'd expect, shares of Tilray and Aphria started to trade more or less in lockstep in the weeks following the merger. Since buyers of Aphria stock would end up with a set number of Tilray shares after the closing of the deal, investors became indifferent to which stock they owned.

However, in recent weeks, that dynamic has changed. As you can see below, Tilray shares have taken off, while Aphria has seen much less dramatic increases. On Wednesday alone, Tilray is up 28%, while Aphria's gains were limited to 7%.

TLRY Chart

TLRY data by YCharts.

The risks of merger arbitrage

Now Tilray shares are worth roughly double those of Aphria. That opens up a potential arbitrage opportunity, as investors should theoretically be able to do the following:

  • Sell short 0.8381 shares of Tilray stock and receive about $45 in proceeds, based on recent share prices around $54
  • Buy one share of Aphria for $25 to $26 per share
  • Wait for the merger to happen, at which point the Aphria share will turn into 0.8381 shares of Tilray
  • Close the short position with the newly acquired Tilray stock and pocket the $19 to $20 in cash

However, there are always risks with merger arbitrage. The biggest is that the merger might not go through. When a deal ends up not happening, the shares often reverse whatever trends they've seen in the run-up to the merger.

In addition, it's not always possible to do the transactions to capture the arbitrage opportunity. Especially with recent short squeezes, institutions are likely reluctant to put their capital at risk trying to exploit the spread.

Watch what you're doing

If you're bullish on the Aphria-Tilray merger and actually want to hold on to shares of the combined company, then the obvious choice here is to buy Aphria rather than Tilray. Yet it'll be interesting to see whether it actually plays out that way -- or whether rallying investors end up bidding Tilray higher while leaving the arbitrage opportunity to get even bigger.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Aphria Stock Quote
Dow Jones Industrial Average (Price Return) Stock Quote
Dow Jones Industrial Average (Price Return)
$31,500.68 (2.68%) $823.32
S&P 500 Index - Price Return (USD) Stock Quote
S&P 500 Index - Price Return (USD)
$3,911.74 (3.06%) $116.01
NASDAQ Composite Index (Price Return) Stock Quote
NASDAQ Composite Index (Price Return)
$11,607.62 (3.34%) $375.43
Canopy Growth Stock Quote
Canopy Growth
$3.77 (4.72%) $0.17
Tilray Stock Quote

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
S&P 500 Returns

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 06/25/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.